Search results
Is BioNTech (BNTX) a Great Value Stock Right Now?
Zacks via Yahoo Finance· 2 years agoHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks....
Should Value Investors Buy BioNTech (BNTX) Stock?
Zacks via Yahoo Finance· 9 months agoHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks....
Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That The Market Could be Wrong Given Its...
Simply Wall St. via Yahoo Finance· 1 year agoWith its stock down 19% over the past month, it is easy to disregard BioNTech (NASDAQ:BNTX). But if...
BioNTech SE's (NASDAQ:BNTX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market...
Simply Wall St. via Yahoo Finance· 7 months agoWith its stock down 12% over the past month, it is easy to disregard BioNTech (NASDAQ:BNTX)....
How Much Upside is Left in BioNTech SE Sponsored ADR (BNTX)? Wall Street Analysts Think 40.69%
Zacks via Yahoo Finance· 9 months agoThe mean of analysts' price targets for BioNTech SE Sponsored ADR (BNTX) points to a 40.7% upside in...
BioNTech Surges On This Promising Update In Its Bid To Take On Bristol Myers In Lung Cancer...
Investor's Business Daily· 11 months agoGerman biotechnology company BioNTech said Friday almost a third of patients with a hard-to-treat...
BioNTech Trims Expenses As Plummeting Covid Vaccine Sales Still Lag Expectations
Investor's Business Daily· 9 months agoGerman biotech BioNTech said Monday it's trimming drug development costs amid plummeting Covid...
BioNTech SE Sponsored ADR (BNTX) Stock Moves -0.79%: What You Should Know
Zacks via Yahoo Finance· 1 year agoIn the latest trading session, BioNTech SE Sponsored ADR (BNTX) closed at $137.53, marking a -0.79%...
Why 'Covid Fatigue' Isn't Enough To Keep BioNTech Down; Shares Surge On Upgrade
Investor's Business Daily· 2 years agoBioNTech snagged an upgrade Wednesday with an analyst saying "Covid fatigue" has obscured its...
Will Weakness in BioNTech SE's (NASDAQ:BNTX) Stock Prove Temporary Given Strong Fundamentals?
Simply Wall St. via Yahoo Finance· 2 months agoWith its stock down 7.5% over the past three months, it is easy to disregard BioNTech (NASDAQ:BNTX)....